The acquisition of Resolution Medical by Resonetics signifies a major step in the group’s expansion toward a comprehensive, full-lifecycle service model. The strategic rationale for this transaction centers on an "integrated-platform" maneuver, merging the target’s technical operational depth in biosimulation and cleanroom assembly with the acquirer’s established scale in laser-based component manufacturing and battery systems. This structural alignment provides the organization with the scientific talent and technological hardware necessary to manage the increasing technical complexity of neuromodulation and structural heart devices.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 13.3x since the beginning of 2026, 1.5% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.